Peripheral Biomarkers in Multiple Sclerosis Patients Treated with Interferon-Beta
Multiple sclerosis is a relapsing and eventually progressive disorder of the central nervous system that continues to challenge researchers who try to understand the pathogenesis of the disease and prevent its progression. Interferon-beta is the most widely prescribed treatment for MS. Peripheral bl...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2021
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/77652 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Peripheral Biomarkers in Multiple Sclerosis Patients Treated with Interferon-Beta
- Biomarkers in Multiple Sclerosis
- When and How to Use Plasma Exchange Therapy for Difficult-to-Treat Multiple Sclerosis Patients
- Mechanisms of Peripheral Nerve Injury – What to Treat, When to Treat
- Perspective Chapter: Impact of Interferon Alpha/Beta in the Management of Chronic Myeloproliferative Disorders
- The Evaluation of New Biomarkers of Inflammation and Angiogenesis in Peripheral Arterial Disease
- Interferons Horizon Therapeutics